Literature DB >> 17667942

Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification.

U Mangold1, H Hayakawa, M Coughlin, K Münger, B R Zetter.   

Abstract

The potential tumor suppressor antizyme and its endogenous inhibitor (antizyme inhibitor, AZI) have been implicated in the ubiquitin-independent proteasomal degradation of proteins involved in cell proliferation as well as in the regulation of polyamine levels. We show here that both antizyme and AZI concentrate at centrosomes and that antizyme preferentially associates with the maternal centriole. Interestingly, alterations in the levels of these proteins have opposing effects on centrosomes. Depletion of antizyme in various cell lines and primary cells leads to centrosome overduplication, whereas overexpression of antizyme reduces numerical centrosome abnormalities. Conversely, silencing of the antizyme inhibitor, AZI, results in a decrease of numerical centrosome abnormalities, whereas overexpression of AZI leads to centrosome overduplication. We further show that the numerical centrosome abnormalities are due to daughter centriole amplification. In summary, our results demonstrate that alterations in the antizyme/AZI balance cause numerical centrosomal defects and suggest a role for ubiquitin-independent proteasomal degradation in centrosome duplication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17667942     DOI: 10.1038/sj.onc.1210685

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Knockdown of ornithine decarboxylase antizyme 1 causes loss of uptake regulation leading to increased N1, N11-bis(ethyl)norspermine (BENSpm) accumulation and toxicity in NCI H157 lung cancer cells.

Authors:  Alison V Fraser; Andrew C Goodwin; Amy Hacker-Prietz; Elizabeth Sugar; Patrick M Woster; Robert A Casero
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

Review 2.  The benefits of local depletion: The centrosome as a scaffold for ubiquitin-proteasome-mediated degradation.

Authors:  Setu M Vora; Bryan T Phillips
Journal:  Cell Cycle       Date:  2016-06-13       Impact factor: 4.534

3.  Recurrent emergence of catalytically inactive ornithine decarboxylase homologous forms that likely have regulatory function.

Authors:  Ivaylo P Ivanov; Andrew E Firth; John F Atkins
Journal:  J Mol Evol       Date:  2010-03-09       Impact factor: 2.395

4.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.

Authors:  Leilei Chen; Yan Li; Chi Ho Lin; Tim Hon Man Chan; Raymond Kwok Kei Chow; Yangyang Song; Ming Liu; Yun-Fei Yuan; Li Fu; Kar Lok Kong; Lihua Qi; Yan Li; Na Zhang; Amy Hin Yan Tong; Dora Lai-Wan Kwong; Kwan Man; Chung Mau Lo; Si Lok; Daniel G Tenen; Xin-Yuan Guan
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

5.  Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo.

Authors:  Rachelle R Olsen; Ivy Chung; Bruce R Zetter
Journal:  Amino Acids       Date:  2011-09-11       Impact factor: 3.520

6.  Antizyme restrains centrosome amplification by regulating the accumulation of Mps1 at centrosomes.

Authors:  Christopher Kasbek; Ching-Hui Yang; Harold A Fisk
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

Review 7.  When 2+2=5: the origins and fates of aneuploid and tetraploid cells.

Authors:  Randall W King
Journal:  Biochim Biophys Acta       Date:  2008-08-07

Review 8.  Antizyme and antizyme inhibitor, a regulatory tango.

Authors:  Chaim Kahana
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

9.  Human papillomavirus type 16 E7 oncoprotein associates with the centrosomal component gamma-tubulin.

Authors:  Christine L Nguyen; Catherine Eichwald; Max L Nibert; Karl Münger
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

10.  Expression of antizyme inhibitor 2 in mast cells and role of polyamines as selective regulators of serotonin secretion.

Authors:  Kristiina Kanerva; Jani Lappalainen; Laura T Mäkitie; Susanna Virolainen; Petri T Kovanen; Leif C Andersson
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.